(Q42823847)

8 November 2017

Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array (English)

1 reference

single-nucleotide polymorphism

8 November 2017

0 references

1 reference

1 reference

Motohiro Kato

4

0 references

author name string

Riki Nishimura

1

1 reference

8 November 2017

Junko Takita

2

1 reference

8 November 2017

Aiko Sato-Otsubo

3

1 reference

8 November 2017

Katsuyoshi Koh

5

1 reference

8 November 2017

Ryoji Hanada

6

1 reference

8 November 2017

Yukichi Tanaka

7

1 reference

8 November 2017

Keisuke Kato

8

1 reference

8 November 2017

Daichi Maeda

9

1 reference

8 November 2017

Masashi Fukayama

10

1 reference

8 November 2017

Masashi Sanada

11

1 reference

8 November 2017

Yasuhide Hayashi

12

1 reference

8 November 2017

Seishi Ogawa

13

1 reference

8 November 2017

23 May 2013

1 reference

8 November 2017

1 reference

8 November 2017

104

1 reference

8 November 2017

856-864

1 reference

8 November 2017

7

1 reference

describes a project that uses

8 November 2017

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

Intergroup Rhabdomyosarcoma Study: update for pathologists.

1 reference

Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma

21 January 2018

1 reference

Molecular genetics and pathogenesis of rhabdomyosarcoma

21 January 2018

1 reference

Allelotype of pediatric rhabdomyosarcoma

21 January 2018

1 reference

Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma

21 January 2018

1 reference

High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis.

21 January 2018

1 reference

A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays

21 January 2018

1 reference

Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays

21 January 2018

1 reference

Oncogenic mutations of ALK kinase in neuroblastoma

21 January 2018

1 reference

Aberrant activation of ALK kinase by a novel truncated form ALK protein in neuroblastoma.

21 January 2018

1 reference

Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays

21 January 2018

1 reference

Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.

21 January 2018

1 reference

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

21 January 2018

1 reference

A method and server for predicting damaging missense mutations

21 January 2018

1 reference

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

21 January 2018

1 reference

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

21 January 2018

1 reference

Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma.

21 January 2018

1 reference

Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels.

21 January 2018

1 reference

Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis.

21 January 2018

1 reference

Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer

21 January 2018

1 reference

A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5.

21 January 2018

1 reference

Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group

21 January 2018

1 reference

PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.

21 January 2018

1 reference

Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group

21 January 2018

1 reference

Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components

21 January 2018

1 reference

Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group

21 January 2018

1 reference

Involvement of insulin receptor substrate 2 in mammary tumor metastasis

21 January 2018

1 reference

Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis.

21 January 2018

1 reference

Insulin receptor substrate-1 and -2 mediate resistance to glucose-induced caspase-3 activation in human neuroblastoma cells

21 January 2018

1 reference

Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways

21 January 2018

1 reference

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

21 January 2018

1 reference

Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling

21 January 2018

1 reference

Role for amplification and expression of glypican-5 in rhabdomyosarcoma

21 January 2018

1 reference

Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group

21 January 2018

1 reference

ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.

21 January 2018

1 reference

Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.

21 January 2018

1 reference

ALK protein expression in rhabdomyosarcomas

21 January 2018

1 reference

Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression

21 January 2018

1 reference

Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma

21 January 2018

1 reference

Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma

21 January 2018

1 reference

12 December 2020

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

1 reference

12 December 2020

A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma

1 reference

12 December 2020

Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family

1 reference

12 December 2020

Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes

1 reference

12 December 2020

Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas.

1 reference

12 December 2020

Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma

1 reference

12 December 2020

Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study

1 reference

12 December 2020

Gene amplifications associated with the development of hormone-resistant prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1111/CAS.12173

1 reference

8 November 2017

1 reference